Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
